Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026)

Harrow (HROW) recorded quarterly Depreciation & Amortization (CF) of $455000.0 in Q1 2026, down 1.94% quarter-over-quarter from $464000.0 in Q4 2025, and down 2.15% on a YoY basis from $465000.0 in Q1 2025.

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Harrow's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $455000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 2.15% year-over-year to $455000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 1.17% YoY), while the FY2025 annual figure was $1.9 million, up 3.51% from the prior year.
  • Depreciation & Amortization (CF) was $455000.0 for Q1 2026 at Harrow, down from $464000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $497000.0 in Q3 2024 to a low of $247000.0 in Q3 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $425117.6 across 5 years, with a median of $435000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 38.1% in 2022, then soared 63.97% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $387000.0 in 2022, then climbed by 12.4% to $435000.0 in 2023, then gained by 7.59% to $468000.0 in 2024, then fell by 0.85% to $464000.0 in 2025, then slipped by 1.94% to $455000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $455000.0 (Q1 2026), $464000.0 (Q4 2025), and $490000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 455,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 455,000.00
Mar 31, 2026 455,000.00
Dec 31, 2025 464,000.00
Dec 31, 2025 464,000.00
Sep 30, 2025 490,000.00
Sep 30, 2025 490,000.00
Jun 30, 2025 496,000.00
Jun 30, 2025 496,000.00
Mar 31, 2025 465,000.00
Mar 31, 2025 465,000.00
Dec 31, 2024 468,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 497,000.00
Sep 30, 2024 497,000.00
Jun 30, 2024 453,000.00
Jun 30, 2024 453,000.00
Mar 31, 2024 432,000.00
Mar 31, 2024 432,000.00
Dec 31, 2023 435,000.00
Dec 31, 2023 435,000.00